Arrieta, A., Hong, J. C., Khera, R., Virani, S. S., Krumholz, H. M., & Nasir, K. (2017). Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial. JAMA Cardiol.
Citação norma ChicagoArrieta, Alejandro, Jonathan C. Hong, Rohan Khera, Salim S. Virani, Harlan M. Krumholz, and Khurram Nasir. "Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial." JAMA Cardiol 2017.
Citação norma MLAArrieta, Alejandro, et al. "Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers: Insights Derived From the FOURIER Trial." JAMA Cardiol 2017.